Westmore · UDRP DecisionTruemetrixteststrips.com
The Panel ordered transfer of <truemetrixteststrips.com>. It found the Domain Name confusingly similar to the Complainant’s TRUE METRIX mark, that the Respondent lacked rights or legitimate interests because the website falsely appeared official or authorized and did not satisfy the Oki Data reseller criteria, and that the Respondent registered and used the Domain Name in bad faith to attract Internet users for commercial gain through confusion with the Complainant.
The timeline behind truemetrixteststrips.com
Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.
Westmore reconstructs the full history behind truemetrixteststrips.com — from public RDAP and the Internet Archive — as part of UDRP Intelligence:
The decision illustrates that uncertainty over whether products are genuine or counterfeit need not prevent a transfer where the respondent’s use fails the disclosure requirements applicable to resellers. The decisive problem was not merely the sale of trademarked products, but the combined use of a mark-plus-product domain, the Complainant’s logo, and affirmative association language that made the website appear official or authorized.
Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.
ARBITRATION AND MEDIATION CENTER ADMINISTRATIVE PANEL DECISION Trividia Health, Inc. v. Robert Jake Case No. D2025-4871 1. The Parties The Complainant is Trividia Health, Inc., United States of America (“United States”), represented by Greenberg Traurig, LLP, United States. The Respondent is Robert Jake, Kazakhstan. 2. The Domain Name and Registrar The disputed domain name <truemetrixteststrips.com> (the “Domain Name”) is registered with Hosting Concepts B.V. d/b/a Registrar.eu. (the “Registrar”). 3. Procedural History The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on November 24, 2025. On November 24, 2025, the Center transmitted by email to the Registrar a request for registrar verification in connection with the Domain Name. On November 25, 2025, the Registrar transmitted by email to the Center its verification response, disclosing registrant and contact information for the Domain Name which differed from the named Respondent (REDACTED FOR PRIVACY) and contact information in the Complaint. The Center sent an email communication to the Complainant on November 26, 2025, providing the registrant and contact information disclosed by the Registrar, and inviting the Complainant to submit an amendment to the Complaint. The Complainant filed an amended Complaint on December 1, 2025. The Center verified that the Complaint together with the amended Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”). In accordance with the Rules, paragraphs 2 and 4, the Center formally notified the Respondent of the Complaint, and the proceedings commenced on December 4, 2025. In accordance with the Rules, paragraph 5, the due date for Response was December 24, 2025. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on December 26, 2025. page 2 The Center appointed Nicholas Smith as the sole panelist in this matter on January 2, 2026. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7. 4. Factual Background The Complainant is a United States company that since 2014 has manufactured and sold a variety of blood glucose monitoring products (including test strips) under the TRUE METRIX brand. It has promoted and sold its TRUE METRIX products through various channels and has its website at “www.trividiahealth.com”. The Complainant has held a trademark registration for the word TRUE METRIX mark (“TRUE METRIX Mark”) in various jurisdictions including the United Kingdom, the United States, and the European Union. The Complainant’s registration of the TRUE METRIX Mark in the United States dates from 2014 (Registration No. 4.637.504, registered November 11, 2024, in classes 5 and 10). The Domain Name was registered on April 25, 2025. The Domain Name resolves to a website (the “Respondent’s Website”) that purports to offer glucose monitoring products under the TRUE METRIX Mark, displays the Complainant’s logo and makes direct reference to the Complainant. 5. Parties’ Contentions A. Complainant The Complainant contends that it has satisfied each of the elements required under the Policy for a transfer of the Domain Name. Notably, the Complainant contends that: a) It is the owner of the TRUE METRIX Mark, having registered the TRUE METRIX Mark in the United States and various other jurisdictions. The Domain Name is confusingly similar to the TRUE METRIX Mark as it merely adds the terms “test strips” and the generic Top-Level Doman (“gTLD”) “.com” to the mark. b) There are no rights or legitimate interests held by the Respondent in respect of the Domain Name. The Complainant has not granted any license or authorization for the Respondent to use the TRUE METRIX Mark. The Respondent is not commonly known by the TRUE METRIX Mark, nor does it use the Domain Name for a bona fide purpose or legitimate noncommercial purpose. Rather the Respondent is using the Domain Name to pass off as the Complainant for commercial gain by reproducing the Complainant’s mark and specific language asserting that the website is connected to the Complainant and purporting to collect personal and financial information and, at worst, to engage in fraudulent transactions, and at best, simply confuse consumers. Such use is not a legitimate use of the Domain Name. c) The Domain Name was registered and is being used in bad faith. The Respondent is using the Domain Name to divert Internet users searching for the Complainant to the Respondent’s Website to disrupt the Complainant’s business and for commercial gain. Such conduct amounts to registration and use of the Domain Name in bad faith. B. Respondent The Respondent did not reply to the Complainant’s contentions. page 3 6. Discussion and Findings A. Identical or Confusingly Similar It is well accepted that the first element functions primarily as a standing requirement. The standing (or threshold) test for confusing similarity involves a reasoned but relatively straightforward comparison between the Complainant’s trademark and the Domain Name. WIPO Overview of WIPO Panel Views on Selected UDRP Questions, Third Edition, (“WIPO Overview 3.0”), section 1.7. The Complainant has shown rights in respect of a trademark or service mark for the purposes of the Policy. WIPO Overview 3.0, section 1.2.1. The entirety of the mark is reproduced within the Domain Name. Accordingly, the Domain Name is confusingly similar to the mark for the purposes of the Policy. WIPO Overview 3.0, section 1.7. Although the addition of other terms, here “test strips” may bear on assessment of the second and third elements, the Panel finds the addition of such terms does not prevent a finding of confusing similarity between the Domain Name and the mark for the purposes of the Policy. WIPO Overview 3.0, section 1.8. The Panel finds the first element of the Policy has been established. B. Rights or Legitimate Interests Paragraph 4(c) of the Policy provides a list of circumstances in which the Respondent may demonstrate rights or legitimate interests in a disputed domain name. Although the overall burden of proof in UDRP proceedings is on the complainant, panels have recognized that proving a respondent lacks rights or legitimate interests in a domain name may result in the difficult task of “proving a negative”, requiring information that is often primarily within the knowledge or control of the respondent. As such, where a complainant makes out a prima facie case that the respondent lacks rights or legitimate interests, the burden of production on this element shifts to the respondent to come forward with relevant evidence demonstrating rights or legitimate interests in the domain name (although the burden of proof always remains on the complainant). If the respondent fails to come forward with such relevant evidence, the complainant is deemed to have satisfied the second element. WIPO Overview 3.0, section 2.1. Having reviewed the available record, the Panel finds the Complainant has established a prima facie case that the Respondent lacks rights or legitimate interests in the Domain Name. The Respondent has not rebutted the Complainant’s prima facie showing and has not come forward with any relevant evidence demonstrating rights or legitimate interests in the Domain Name such as those enumerated in the Policy or otherwise. The Panel considers that the record of this case reflects that: - before any notice to the Respondent of the dispute, the Respondent did not use, nor has it made demonstrable preparations to use, the Domain Name or a name corresponding to the Domain Name in connection with a bona fide offering of goods or services. Paragraph 4(c)(i) of the Policy, and WIPO Overview 3.0, section 2.2. - the Respondent (as an individual, business, or other organization) has not been commonly known by the Domain Name. Paragraph 4(c)(ii) of the Policy, and WIPO Overview 3.0, section 2.3. - the Respondent is not making a legitimate noncommercial or fair use of the Domain Name, without intent for commercial gain to misleadingly divert consumers or to tarnish the trademark or service mark at issue. Paragraph 4(c)(iii) of the Policy, and WIPO Overview 3.0, section 2.4. page 4 - the record contains no other factors demonstrating rights or legitimate interests of the Respondent in the Domain Name. The Respondent has used the Domain Name to operate a website to sell glucose monitoring products that purport to be legitimate TRUE METRIX products. It is unclear whether the products sold are counterfeit or genuine products produced by the Complainant. If the glucose monitoring products sold on the Respondent’s Website are not genuine products produced by the Complainant, the Respondent’s use of the Domain Name does not grant it rights or legitimate interests since it is using the Complainant’s TRUE METRIX Mark for a site selling counterfeit products. Even if the Respondent is offering genuine TRUE METRIX products from the Respondent’s Website, such use does not automatically grant it rights or legitimate interests. The principles that govern whether a reseller of genuine goods has rights or legitimate interests have been set out in a variety of UDRP decisions, starting with the case of Oki Data Americas, Inc. v. ASD, Inc., WIPO Case No. D2001-0903 (“Oki Data test”). The WIPO Overview 3.0, section 2.8 summarizes the consensus views of UDRP panels in assessing claims of nominative (fair) use by resellers or distributors in the following manner: “... Panels have recognized that resellers, distributors, or service providers using a domain name containing the complainant’s trademark to undertake sales or repairs related to the complainant’s goods or services may be making a bona fide offering of goods and services and thus have a legitimate interest in such domain name. Outlined in the ‘Oki Data test’, the following cumulative requirements will be applied in the specific conditions of a UDRP case: (i) the respondent must actually be offering the goods or services at issue; (ii) the respondent must use the site to sell only the trademarked goods or services; (iii) the site must accurately and prominently disclose the registrant’s relationship with the trademark holder; and (iv) the respondent must not try to “corner the market” in domain names that reflect the trademark. The “Oki Data test” does not apply where any prior agreement, express or otherwise, between the parties expressly prohibits (or allows) the registration or use of domain names incorporating the complainant’s trademark.” In this case, the Respondent’s Website does not accurately or prominently disclose the Respondent’s relationship with the Complainant, in particular that it is not an authorized dealer or has any particular connection with the Complainant. Rather the nature of the Domain Name itself, which incorporates the Complainant’s mark and the terms descriptive of its products, the absence of a disclaimer and the presence of various statements that actively assert that the Respondent’s Website is associated with the Complainant (e.g. “True Metrix by Trividia Health empowers you to manage diabetes with accurate, easy-to -use blood glucose monitoring systems. Featuring TRIPLE SENSE TECHNOLOGY® and advanced event tagging, our meters deliver reliable results in as fast as 4 seconds. Explore our range of affordable, high-quality solutions designed to fit your lifestyle and support your health journey with confidence”) results in the impression that the Respondent’s Website is an official website of the Complainant or an authorized reseller. Under the circumstances of this case, even in the event that the Respondent is reselling genuine TRUE METRIX products, its use of the Domain Name for the Respondent’s Website does not grant it rights or legitimate interests in the Domain Name. The Panel finds the second element of the Policy has been established. page 5 C. Registered and Used in Bad Faith The Panel notes that, for the purposes of paragraph 4(a)(iii) of the Policy, paragraph 4(b) of the Policy establishes circumstances, in particular, but without limitation, that, if found by the Panel to be present, shall be evidence of the registration and use of a domain name in bad faith. The Panel finds that the Respondent must have been aware of the Complainant and its reputation in the TRUE METRIX Mark at the time the Respondent registered the Domain Name. The Respondent has provided no explanation, and neither is it immediately obvious, why an entity would register a domain name that wholly incorporates the TRUE METRIX Mark and direct it to a website purportedly offering glucose monitoring products under the Complainant’s TRUE METRIX Mark (non-complying with the requirements of the Oki Data test) unless there was an awareness of and an intention to create a likelihood of confusion with the Complainant and its TRUE METRIX Mark. Furthermore, as discussed earlier in the Decision, the Respondent’s Website contains false statements that imply that the Respondent’s Website is operated by the Complainant. The registration of the Domain Name in awareness of the TRUE METRIX Mark and in the absence of rights or legitimate interests amounts under these circumstances to registration in bad faith. The Panel considers that the record of this case reflects that the Respondent has passed off as the Complainant and purported to offer glucose monitoring products, be they genuine or otherwise, under the Complainant’s TRUE METRIX Mark on the Respondent’s Website without the Complainant’s approval and without meeting the Oki Data test. The Panel finds that the Respondent is using the Domain Name to intentionally attempt to attract, for commercial gain, Internet users to its website by creating a likelihood of confusion with the TRUE METRIX Mark as to the source, sponsorship, affiliation, or endorsement of the Respondent’s Website. Paragraph 4(b)(iv) of the Policy, and WIPO Overview 3.0, section 3.1.4. The Panel finds that the Complainant has established the third element of the Policy. 7. Decision For the foregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the Domain Name <truemetrixteststrips.com> be transferred to the Complainant. /Nicholas Smith/ Nicholas Smith Sole Panelist Date: January 7, 2025
Source of record: WIPO . Reproduced for research; WIPO is the authoritative source.
What Westmore sees around truemetrixteststrips.com
The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.

A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.
Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.
The decision is only the beginning.
You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.
Go beyond the public record: see how this case has been cited, find comparable decisions, analyze the panelist and apply the relevant authorities to your Matter.
Westmore Professional · $395/month
Research with UDRP IntelligenceWestmore AI drafts an attorney-review-ready UDRP response from your facts, grounded in the exact panel and closest precedent.
$895 one-time per matter · no subscription required. Self-help drafting aid — not legal advice.
Build your responseWestmore UDRP records draw on WIPO-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.